Mississippi House Bill HB1511

Mississippi 2024 Regular Session

• Introduced: 2/19/24
• Refer: 2/19/24
• Failed: 3/5/24

Caption

Ivermectin; authorize pharmacists to provide to adults pursuant to collaborative pharmacy practice agreement.

Impact

The bill places a duty on the Mississippi Board of Pharmacy to establish standard procedures for the distribution of ivermectin, which includes creating a risk assessment tool and a standardized fact sheet for patients. Additionally, pharmacists will have the authority to charge administrative fees for services related to the dispensing of ivermectin, which could potentially change how pharmacies operate and generate revenue. By doing so, the legislation could enhance access to ivermectin while also regulating how pharmacists deliver this service.

Summary

House Bill 1511 seeks to authorize pharmacists in Mississippi to provide ivermectin to adults aged eighteen and older. This provision would occur under a collaborative pharmacy practice agreement, which includes a non-patient-specific prescriptive order developed by authorized practitioners. The bill aims to streamline the process by which patients can access ivermectin through pharmacies, ensuring they are also provided with relevant screening tools and information about the medication's usage and follow-up care.

Contention

A significant point of contention surrounding HB1511 is the immunity it provides to pharmacists and practitioners involved in the provision of ivermectin. While this legal protection is intended to encourage pharmacists to dispense ivermectin confidently and safely, concerns may arise regarding accountability particularly if adverse outcomes occur. Critics might argue that this immunity provision could undermine patient safety standards and reduce oversight, leading to questionable practices in the future. Ultimately, balancing accessibility to treatment with maintaining high medical standards and protections for patients will be essential as the bill is considered.